Valerie Horsley, PhD
Yale University
Biography:
Dr. Valerie Horsley is a cell/developmental biologist who is a Professor of Molecular, Cellular, and Developmental Biology at Yale University and of Dermatology at the Yale School of Medicine. She is a member of the Yale Stem Cell Center and Yale Cancer Center. Dr. Horsley received her undergraduate degree in Biology from Furman University, her PhD in Biochemistry, Cell, and Developmental Biology from Emory University, and completed postdoctoral training at Rockefeller University. Her lab uses mouse genetics, genomic technology, and cell biology to study skin development, repair, and homeostasis. In her laboratory, Dr. Horsley and her team investigate the essential biological interactions that regenerate tissues. Using multipronged approaches including mouse genetics, cell culture models, genomics, metabolomics, and microscopy, they define novel mechanisms that underpin regenerative biology. This work has revealed several aspects of tissue regeneration and fibrosis by investigating the connective tissue or stroma cells including fibroblast-lineage cell fate plasticity, lipid storage/release, regulation of inflammation, and new cellular interactions that drive blood vessel repair or angiogenesis. Dr. Horsley's contributions extend beyond the laboratory as she has been instrumental in organizing stem cell niche and fibrosis communities as well as serving in several leadership roles at Yale including Chair of Yale's Faculty of Arts and Science and Engineering Senate and in international research societies. Dr. Horsley and her team's contributions to the field have been recognized by the Pew Foundation, Genetics Society of America, the Society for Investigative Dermatology, the Presidential Early Career Award in Science and Engineering from the White House, and the Society for Matrix Biology.
Abstract:
Tissues are dynamic systems that must continuously balance homeostasis with the capacity to respond to injury and disease. When challenged, tissues mount a coordinated response, encompassing inflammation, cellular repair, and matrix remodeling, that is essential for restoring function. However, the signals that determine whether tissue health resolves normally or becomes pathological remain poorly understood. Identifying these signals is critical, as dysregulated repair underlies fibrotic and inflammatory diseases across virtually every organ system. Our work focuses on the tissue niche as the key determinant of repair outcomes. We have identified two classes of niche signals that are central regulators of this process. Locally derived nutrients act as dynamic, tunable cues that orchestrate cellular behavior across the phases of repair. Disruption of either program impairs repair and promotes chronic inflammation, with direct parallels to human fibrotic and metabolic disease. Matrix stiffness operates through a distinct but complementary mechanism: as tissue stiffens during pathological remodeling, mechanical signals are transduced to the nucleus, remodeling chromatin accessibility at fibrotic gene loci and actively reinforcing the diseased state. Together, these findings reframe tissue pathology as a niche-driven process in which metabolic and mechanical signals converge on the genome to determine whether repair restores function or progresses to disease. Understanding how these signals are integrated across tissues may open new therapeutic avenues for diseases spanning from inflammatory conditions, cancer, and fibrosis.
Dr. Valerie Horsley is a cell/developmental biologist who is a Professor of Molecular, Cellular, and Developmental Biology at Yale University and of Dermatology at the Yale School of Medicine. She is a member of the Yale Stem Cell Center and Yale Cancer Center. Dr. Horsley received her undergraduate degree in Biology from Furman University, her PhD in Biochemistry, Cell, and Developmental Biology from Emory University, and completed postdoctoral training at Rockefeller University. Her lab uses mouse genetics, genomic technology, and cell biology to study skin development, repair, and homeostasis. In her laboratory, Dr. Horsley and her team investigate the essential biological interactions that regenerate tissues. Using multipronged approaches including mouse genetics, cell culture models, genomics, metabolomics, and microscopy, they define novel mechanisms that underpin regenerative biology. This work has revealed several aspects of tissue regeneration and fibrosis by investigating the connective tissue or stroma cells including fibroblast-lineage cell fate plasticity, lipid storage/release, regulation of inflammation, and new cellular interactions that drive blood vessel repair or angiogenesis. Dr. Horsley's contributions extend beyond the laboratory as she has been instrumental in organizing stem cell niche and fibrosis communities as well as serving in several leadership roles at Yale including Chair of Yale's Faculty of Arts and Science and Engineering Senate and in international research societies. Dr. Horsley and her team's contributions to the field have been recognized by the Pew Foundation, Genetics Society of America, the Society for Investigative Dermatology, the Presidential Early Career Award in Science and Engineering from the White House, and the Society for Matrix Biology.
Abstract:
Tissues are dynamic systems that must continuously balance homeostasis with the capacity to respond to injury and disease. When challenged, tissues mount a coordinated response, encompassing inflammation, cellular repair, and matrix remodeling, that is essential for restoring function. However, the signals that determine whether tissue health resolves normally or becomes pathological remain poorly understood. Identifying these signals is critical, as dysregulated repair underlies fibrotic and inflammatory diseases across virtually every organ system. Our work focuses on the tissue niche as the key determinant of repair outcomes. We have identified two classes of niche signals that are central regulators of this process. Locally derived nutrients act as dynamic, tunable cues that orchestrate cellular behavior across the phases of repair. Disruption of either program impairs repair and promotes chronic inflammation, with direct parallels to human fibrotic and metabolic disease. Matrix stiffness operates through a distinct but complementary mechanism: as tissue stiffens during pathological remodeling, mechanical signals are transduced to the nucleus, remodeling chromatin accessibility at fibrotic gene loci and actively reinforcing the diseased state. Together, these findings reframe tissue pathology as a niche-driven process in which metabolic and mechanical signals converge on the genome to determine whether repair restores function or progresses to disease. Understanding how these signals are integrated across tissues may open new therapeutic avenues for diseases spanning from inflammatory conditions, cancer, and fibrosis.
